Benzinga

SEPTEMBER 16, 2022

Radiopharm Theranostics Ltd (ASX:RAD) shares were trading 9% higher intra-day, at 18 cents, after securing a rare paediatric disease (RPD) designation for its DUNP19 technology for treating osteosarcoma by the US Food & Drug Administration (FDA). Sydney, Sept. Click here.

Technology 40

Technology 40

Benzinga

MAY 17, 2022

Sydney, May 18, 2022 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies: Provaris Energy Ltd (ASX:PV1) has advanced engineering design work to 70% for its GH2 Carrier Provaris H2Neo and this work remains on track for final delivery in June 2022.

40

40

Benzinga

SEPTEMBER 6, 2022

New York , Sept. 06, 2022 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies: Netflix will not allow cryptocurrency-related advertisements, sources say click here. Arrow Exploration receives ‘Buy' rating and C$0.54

Technology 40

Technology 40

Benzinga

OCTOBER 21, 2022

A Media Snippet accompanying this announcement is available by clicking on the image or link below: For more information, please view the InvestmentPitch Media video which provides additional information about this news and the company. The video is available for viewing on " InvestmentPitch " and on " YouTube ".

Marketability 40

Marketability 40

Benzinga

APRIL 11, 2022

Sydney, April 12, 2022 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies: Legacy Minerals Ltd (ASX:LGM) has received high-grade zinc, lead, gold and silver assay results from drilling at the 100% owned Bauloora Project in New South Wales.

40

40

Benzinga

NOVEMBER 23, 2022

Race Oncology Ltd (ASX:RAC) has received confidential and constructive guidance during a pre-investigational new drug (pre-IND) meeting with the US Food and Drug Administration (FDA) for its asset Zantrene (bisantrene dihydrochloride). Sydney, Nov. Click here.

40

40

Benzinga

MAY 26, 2022

New York , May 26, 2022 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies: Sigma Lithium announces integrated Phase 1 & 2 technical report with post-tax net present value of $5.1B

Technology 40

Technology Net Present Value Marketability 40

Benzinga

JUNE 27, 2022

Sydney, June 28, 2022 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies: Radiopharm Theranostics Ltd (ASX:RAD) has made a poster presentation featuring its AV?6-Integrin Click here. Click here. million (A$22.3 million).

Technology 40

Technology 40

Benzinga

JANUARY 17, 2023

"Today's announcement is good news for our stakeholders and the Reducer program," said Fred Colen, Neovasc's President and Chief Executive Officer. "We Under the terms of the Arrangement Agreement, Neovasc shareholders will receive US$27.25 Each CVR will pay: (i) US$12.00

Enterprise Value 40

Enterprise Value Marketability Technology 40

Benzinga

FEBRUARY 22, 2023

ROCK2 inhibition is now a commercially validated target with potential in multiple disease areas, following the recent US FDA approval and launch of the first drug with this mechanism of action. This announcement follows the earlier news 1 that Jounce plans to reduce its workforce by approximately 57%. Richard Murray, Ph.D.,

Market Capitalization 40

Market Capitalization Marketability 40

Benzinga

MARCH 27, 2023

Benzinga Elon Musk-Led Neuralink Seeks Collaborators For Human Trials Of Brain-Implanted Chips Despite concerns about potential animal-welfare violations, Elon Musk -led Neuralink is searching for a suitable partner to conduct human clinical trials of its brain-implanted chips. to explore the possibility of partnering for clinical trials.

Banking 98

Banking Marketability 98

Benzinga

NOVEMBER 18, 2022

Elon Musk's Ultimatum Triggers Mass Exodus At Twitter As Social Media Site Reportedly At Risk Of 'Breaking During Night' There are mounting concerns over the stability of Twitter's platform after hundreds of employees chose to exit the company instead of agreeing to work "long hours at high intensity."

Finance 98

Finance Marketability 98

Benzinga

SEPTEMBER 29, 2022

Safe Harbor Statement Statements in this news release about Isoray's future expectations, including: the anticipated synergies and benefits of the proposed merger with Viewpoint Molecular Targeting, Inc., Follow us on LinkedIn and Twitter.

Alpha 40

Alpha Marketability Technology Compliance 40

Benzinga

JULY 11, 2022

The move comes after a new wave is underway in Europe, with increasing hospital and intensive care unit rates. Perrigo Company plc's (NYSE: PRGO ) HRA Pharma has submitted its application to the FDA for the first-ever over-the-counter (OTC) birth control pill. Perrigo Files US Application For First OTC Birth Control Pill.

98

98

Benzinga

JULY 5, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus. AstraZeneca Strengthens Its Hematological Cancer Pipeline With TeneoTwo Acquisition.

Technology 98

Technology Equity Finance 98

Benzinga

JULY 7, 2022

FDA Institutes Clinical Hold On DiaMedica's Late-Stage Stroke Trial. The FDA placed a clinical hold on DiaMedica Therapeutics Inc.'s A purchase agreement is expected in the next few weeks, according to the Wall Street Journal citing people familiar with the matter.

98

98

Benzinga

JUNE 27, 2022

An additional 70 cents per CVR is payable upon FDA approval for Tazverik and R2 combo in second-line follicular lymphoma by Jan. Each CVR entitles deferred cash payments of 30 cents payable upon the first achievement of $250 million in sales of Tazverik in any period of four consecutive quarters by 2026.

98

98

Benzinga

AUGUST 4, 2022

As a result, and as previously disclosed, the Company has suspended further enrollment activities and is conducting an interim analysis of the data during the third quarter of 2022 to determine the next steps for the program, which may require a discussion with and guidance from FDA. About Caladrius Biosciences. Caladrius Biosciences, Inc.

Start-ups 40

Start-ups Marketability Technology 40

Benzinga

MAY 10, 2022

PRAX-944 was generally well tolerated in Part B of the Phase 2a study, with no new safety findings. Eisai Co Ltd (OTC: ESALY ) has completed the rolling submission of the FDA marketing application under the accelerated approval for lecanemab (BAN2401) for mild cognitive impairment due to Alzheimer's disease (AD) and mild AD.

Marketability 97

Marketability Finance 97

Benzinga

APRIL 29, 2022

Bristol Myers' Oral Heart Disease Drug Scores FDA Approval. The FDA has approved Bristol Myers Squibb & Co's (NYSE: BMY ) Camzyos (mavacamten) for obstructive hypertrophic cardiomyopathy (obstructive HCM) to improve functional capacity and symptoms. Stocks In Focus.

98

98

Benzinga

APRIL 27, 2022

Pfizer Inc (NYSE: PFE ) and BioNTech SE (NASDAQ: BNTX ) have submitted an FDA Emergency Use Authorization (EUA) application for a 10-µg booster dose of COVID-19 Vaccine for children 5 through 11 years of age. Click here to access Benzinga's FDA Calendar. The FDA has granted. Stocks In Focus. MOLN shares are down 37.9%

Finance 97

Finance 97

Benzinga

APRIL 13, 2022

Click here to access Benzinga's FDA Calendar. Sierra's momelotinib complements GSK's Blenrep, building on GSK's commercial and medical expertise in hematology. SRRA shares are gaining 37.8% during the premarket trading. ProQR Discontinues Working On Inherited Retinal Disease Programs. ProQR Therapeutics N.V.

Equity 98

Equity Technology 98

Benzinga

JULY 10, 2023

Infinity Pharmaceuticals Inc (NASDAQ: INFI ) announced further design features of its Phase 2 MARIO-8 study in Squamous Cell Cancer of the Head and Neck (SCCHN).

52

52

Benzinga

MAY 15, 2023

Google Launches Tools To Detect Fake Images And Curb Misinformation Alphabet Inc plans to add new features to its Image Search tool to help users find the authentic source of an image in a bid to identify misleading AI pictures. Bloomberg Creating Images Via AI?

Marketability 52

Marketability 52

Benzinga

JANUARY 9, 2023

Apple's India-Made iPhone Exports Surpass $2.5B In 9 Months — Nearly Twice Previous Fiscal Year's Total. Apple Inc (NASDAQ: AAPL ) exported more than $2.5 billion worth of iPhones from India between April and December as the company diversified production amid supply disruptions in China.

Banking 52

Banking Marketability 52

Benzinga

NOVEMBER 22, 2022

China To Reportedly Impose Over $1B Fine On Jack Ma's Ant Group Ending 2-Year Long Regulatory Overhaul. Ending Jack Ma's Ant Group's two-year-long regulatory feud, Chinese authorities will reportedly impose a fine of more than $1 billion on the billionaire's fintech company.

Start-ups 52

Start-ups Banking Technology Marketability 52

Benzinga

NOVEMBER 2, 2022

Twitter On A Downsizing Rampage Since Musk Takeover; Terminates Key Ad And Marketing Officials. Tesla Inc (NASDAQ: TSLA ) CEO Elon Musk took over Twitter Inc (NYSE: TWTR ) under a $44 billion deal which followed the firing of CEO Parag Agrawal, Chief Financial Officer Ned Segal, and legal affairs and policy chief Vijaya Gadde.

Marketability 52

Marketability 52

ThomsonReuters

AUGUST 4, 2022

News Release. Based on recommendations published by the federal Health Resources and Services Administration (HRSA) (see our Checkpoint article ), plans generally must cover, without cost-sharing, at least one form of contraception in each category identified in the current FDA Birth Control Guide. Reasonable Medical Management.

52

52

Benzinga

AUGUST 4, 2022

The FDA granted orphan drug designation to tamibarotene in MDS in February 2022. Data from the pivotal trial are expected in Q4 of 2023 or Q1 of 2024, with a potential new drug application filing in 2024. FDA Says Travere's Sparsentan Data Not Sufficient For Accelerated Approval In One Indication.

Finance 52

Finance 52

Benzinga

MAY 17, 2022

Food and Drug Administration (FDA) for its investigational new drug application (IND) of Abivertinib (Fujovee) for patients with metastatic castrate resistant prostate cancer (mCRPC) in the Phase 2 MAVERICK clinical study. Sorrento Therapeutics, Inc. NASDAQ: SRNE ) received clearance from the U.S. The MAVERICK.

52

52

Benzinga

AUGUST 18, 2022

A Media Snippet accompanying this announcement is available by clicking on the image or link below: For more information, please view the InvestmentPitch Media video which provides additional information about this news and the company. The video is available for viewing on " InvestmentPitch " and on " YouTube ".

40

40

Benzinga

APRIL 13, 2023

Benzinga FTX's Native Token Skyrockets 96% As Reports Swirl Of A Possible Relaunch Troubled cryptocurrency exchange FTX's native token FTT (FTT/USD) is up 96% in the last 24 hours, as news emerged that the exchange might be considering restarting in the future. The abortion pill mifepristone will remain available in the U.S.

Technology 52

Technology Marketability 52

Reynolds Holding

MARCH 27, 2023

The stock allegedly fell 13% on this news. alleging that the company “issued over one dozen materially false and/or misleading statements” regarding its purported newly developed COVID-19 testing device, including that it was on the verge of FDA approval. In re Danimer Scientific, Inc. and its CEO.

Technology 59

Technology Start-ups Compliance Finance 59

Reynolds Holding

JULY 4, 2022

Instead, the major news of recent years has been the emergence of a new theory by which to curb the Administrative State: the “Major Questions” doctrine. dissenting) (suggesting a new test for the nondelegation doctrine). [9] 10] See e.g., FDA v. 2116, 2131 (2019) (Gorsuch J., 9] Chevron U.S.A., NRDC, Inc. , 837 (1984).

119

119